IRIS
CHIMENTI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.443
EU - Europa 4.303
AS - Asia 2.178
AF - Africa 65
SA - Sud America 50
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 22
Totale 51.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 44.370
CN - Cina 920
UA - Ucraina 770
DE - Germania 718
SG - Singapore 635
IT - Italia 511
IE - Irlanda 480
SE - Svezia 399
FR - Francia 341
GB - Regno Unito 303
KR - Corea 174
FI - Finlandia 169
RU - Federazione Russa 156
PL - Polonia 150
IN - India 79
CA - Canada 61
BE - Belgio 46
NL - Olanda 45
PK - Pakistan 41
JP - Giappone 37
AU - Australia 34
HK - Hong Kong 34
TR - Turchia 34
CH - Svizzera 33
EG - Egitto 33
ES - Italia 33
VN - Vietnam 31
ID - Indonesia 28
BR - Brasile 27
IR - Iran 25
RO - Romania 25
KG - Kirghizistan 21
UZ - Uzbekistan 21
TW - Taiwan 20
EU - Europa 19
HU - Ungheria 17
PH - Filippine 15
SK - Slovacchia (Repubblica Slovacca) 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
GR - Grecia 14
IL - Israele 14
PT - Portogallo 13
EE - Estonia 10
NG - Nigeria 10
MX - Messico 9
ZA - Sudafrica 9
IQ - Iraq 8
AT - Austria 7
MY - Malesia 7
PE - Perù 7
CL - Cile 6
DK - Danimarca 6
HR - Croazia 6
TH - Thailandia 6
NO - Norvegia 5
RS - Serbia 5
AR - Argentina 4
BJ - Benin 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
CO - Colombia 3
EC - Ecuador 3
KW - Kuwait 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
ET - Etiopia 2
LB - Libano 2
MD - Moldavia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
GP - Guadalupe 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
NA - Namibia 1
NP - Nepal 1
OM - Oman 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 51.099
Salva come PNG Salva come JPEG
Città #
Woodbridge 13.836
Wilmington 10.937
Houston 9.548
Fairfield 1.612
Ann Arbor 1.279
Chandler 1.067
Ashburn 816
Jacksonville 684
Seattle 673
Cambridge 569
Singapore 522
Dublin 477
Medford 387
Dearborn 291
Beijing 288
Zhengzhou 265
New York 206
Lawrence 183
Kraków 137
Santa Clara 124
Rome 118
San Diego 98
Mülheim 87
Menlo Park 86
Shanghai 79
Boardman 72
Moscow 66
Redwood City 62
San Mateo 39
Hefei 37
Milan 37
Nanjing 35
London 32
Norwalk 32
Brussels 29
University Park 28
Jönköping 26
Guangzhou 25
Falls Church 24
Toronto 24
Verona 24
Hangzhou 21
Kunming 20
Mountain View 20
Palo Alto 20
Nanchang 19
Dong Ket 18
Munich 18
Auburn Hills 17
Duncan 14
Tokyo 14
Los Angeles 13
Redmond 13
Stockholm 13
Detroit 12
Dubai 12
Fuzhou 12
Helsinki 12
Jakarta 12
Jinan 11
Phoenix 11
Budapest 10
Central 10
Lahore 10
Madrid 10
Saint Petersburg 10
Salcedo 10
Cairo 9
Hounslow 9
Ottawa 9
Pune 9
São Paulo 9
Bucharest 8
Clearwater 8
Hanoi 8
Lagos 8
Nuremberg 8
Nürnberg 8
Paris 8
Taipei 8
Tallinn 8
Wuhan 8
Augusta 7
Lima 7
Melbourne 7
Seoul 7
Utrecht 7
Washington 7
Berlin 6
Chengdu 6
Chicago 6
Groningen 6
Indiana 6
Islamabad 6
Leawood 6
Napoli 6
New Delhi 6
Amsterdam 5
Bankeryd 5
Bari 5
Totale 45.559
Salva come PNG Salva come JPEG
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.390
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.171
Atopic dermatitis and dental manifestations 476
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 469
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 461
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 459
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 440
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 433
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 431
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 431
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 430
Treatment of trachyonychia with tazarotene 426
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 424
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 420
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 419
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 417
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 415
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 412
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 411
New topical treatments for psoriasis 409
Apremilast for the treatment of psoriasis. 408
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 408
Tazarotene as alternative topical treatment for onychomycosis 408
Actinic keratosis treated with an immune response modifier: a case report of six patients 406
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 406
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 406
The significance of the development of antinuclear antibodies during infliximab treatment 400
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 400
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 398
Lung nodule and facial erythematous plaques: a quiz 398
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 397
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 395
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 395
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 394
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 394
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 391
Topical lactoferrin can improve stable psoriatic plaque 390
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 389
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 386
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 385
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 384
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 384
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 382
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 382
Severe acne successfully treated with etanercept 381
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 381
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 380
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 380
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 379
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 377
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 377
Stress reactivity in psoriatic patients 376
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 376
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 374
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 373
Treatment of lentigo maligna with tazarotene 0.1% gel 372
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 371
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 371
Phrynoderma: a cutaneous sign of an inadequate diet 367
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 366
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 365
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 363
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 361
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 360
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 358
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 358
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 357
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 357
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 354
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 354
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 352
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 350
Zosteriform metastasis of occult bronchogenic carcinoma 350
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 349
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 348
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 347
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 347
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 346
Tofacitinib for the treatment of psoriasis 345
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 345
Metastatic Crohn's disease of the forehead 344
Erysipeloid cutaneous metastasis from bladder carcinoma 338
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 338
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 338
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 336
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 336
Pyoderma vegetans and ulcerative colitis 333
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 331
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 331
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 331
Green sweating spots on hands and feet: unusual expression of hyperbilirubinemia 330
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 330
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 329
Zosteriform metastasis of occult bronchogenic carcinoma 328
Does metabolic syndrome influence psoriasis? 326
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 326
Immunologic biomarkers for clinical and therapeutic management of psoriasis 325
Dermatomyositis associated with ovarian transitional cell carcinoma 324
Insight into genetics of atopic dermatitis: future approaches and directions 324
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 323
Totale 39.518
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.538 0 0 876 1.213 1.010 1.364 1.157 1.198 1.073 1.105 674 868
2020/20217.104 777 802 745 867 634 674 794 695 313 240 409 154
2021/20222.158 88 275 151 139 59 177 104 115 146 186 142 576
2022/20232.793 260 230 142 409 236 586 183 156 290 27 172 102
2023/20241.156 120 52 81 50 105 290 81 106 23 38 25 185
2024/20251.003 177 811 15 0 0 0 0 0 0 0 0 0
Totale 51.894